enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Oxford–AstraZeneca COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID...

   The Oxford–AstraZeneca COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID-19 in adults aged 18 years and older. [1] The medicine is administered by two 0.5 ml (0.017 US fl oz) doses given by intramuscular injection into the deltoid muscle (upper arm).

3. AstraZeneca buys respiratory vaccine developer Icosavax in $1 ...

   www.aol.com/news/astrazeneca-buy-rsv-vaccine...

   AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion. Icosavax is developing a combination vaccine ...

4. AstraZeneca: US data shows vaccine effective for all ages - AOL

   www.aol.com/news/astrazeneca-says-us-trial-data...

   The AstraZeneca shot is a pillar of a U.N.-backed project known as COVAX that aims to get COVID-19 vaccines to poorer countries, and it has also become a key tool in European countries’ efforts ...

5. COVID-19 vaccination in Canada - Wikipedia

   en.wikipedia.org/wiki/COVID-19_vaccination_in_Canada

   On March 1, 2021, two days after the first delivery of the vaccine, the NACI announced that it would recommend that the Oxford-AstraZeneca vaccine not be given to patients older than 65 due to “the insufficiency of evidence of efficacy in this age group at this time.” This recommendation was based on clinical trial data that only went as ...

6. History of COVID-19 vaccine development - Wikipedia

   en.wikipedia.org/wiki/History_of_COVID-19...

   The EMA released an update on the status of its rolling review of the COVID‑19 Vaccine AstraZeneca in December 2020, after the UK granted a temporary authorization of supply for the vaccine. In November 2020, the EMA published a safety monitoring plan and guidance on risk management planning (RMP) for COVID‑19 vaccines.

7. AstraZeneca's Tagrisso-chemo combo given priority review in US

   www.aol.com/news/astrazenecas-tagrisso-chemo...

   (Reuters) -A combination of AstraZeneca's blockbuster cancer drug Tagrisso, with chemotherapy to treat a type of lung cancer, has been accepted and granted priority review by the U.S. Food and ...

8. Stuck: How Vaccine Rumors Start and Why They Don't Go Away

   en.wikipedia.org/wiki/Stuck:_How_Vaccine_Rumors...

   RA638 .L37 2020. Stuck: How Vaccine Rumors Start and Why They Don't Go Away (2020), published by Oxford University Press and written by the director of the London School of Hygiene and Tropical Medicine 's Vaccine Confidence Project, Heidi Larson, looks at what influences attitudes to vaccination. It was largely compiled before the COVID-19 ...

9. AstraZeneca asks the FDA to let adults give themselves the ...

   www.aol.com/finance/astrazeneca-asks-fda-let...

   AstraZeneca is asking the FDA to approve its nasal flu vaccine, FluMist, for use at home — a move that would make it the first ever self-administered vaccine.The pharmaceutical giant announced ...